Asthma Slide Rule
The asthma slide rule helps to start a conversation with your patients and colleagues around how much salbutamol is acceptable before a review is necessary
Asthma Right Care (ARC) is a global initiative led by the International Primary Care Respiratory Group (IPCRG) to explore how to use social movement approaches to create a sense of discomfort and dissatisfaction with the status quo in the management of asthma in a manner that’s positive and creates a sense of hope. Other examples of social movements include the ‘hello my name is’ campaign and antibiotic guardianship.
The challenge of implementing clinical guidelines into practice has been widely documented, and further guidelines may not be the solution. The first phase of the ARC project takes a different approach built around the concept of producing conversation starters that allow people to come to their own conclusions for their role or area with regard to the over-reliance on short-acting beta2 agonists (SABAs).
The asthma slide rule, piloted across four countries, including the UK, is great tool that you can use to stimulate such conversations with professional colleagues and patients.
- These guidance notes provide potential steps and questions to ask when using the ARC SlideRule.
- Watch PCRS member Darush Attar in this video using the ARC slide rule during the UK pilot project.
- You can access an online version of the slide rule on our website.
The Asthma Right Care initiative was originated by the IPCRG with funding from AstraZeneca internationally. The adaptation of materials by PCRS for use in the UK has been funded by AstraZeneca UK Limited.
Asthma Right Care (ARC) is a global social movement created by the International Primary Care Respiratory Group (IPCRG) to drive change and disrupt the status quo in asthma management. Here you'll find podcasts, webinars, practical guidance and patient tools to help improve asthma outcomes.
The asthma slide rule helps to start a conversation with your patients and/or colleagues around how much salbutamol is acceptable before a review is necessary